Literature DB >> 22855475

Viral infections trigger exacerbations of cystic fibrosis in adults and children.

Peter A B Wark, Melinda Tooze, Linda Cheese, Bruce Whitehead, Peter G Gibson, Katrina F Wark, Vanessa M McDonald.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22855475     DOI： 10.1183/09031936.00202311

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  25 in total

1.  Anti-PcrV antibody in cystic fibrosis: a novel approach targeting Pseudomonas aeruginosa airway infection.

Authors:  Carlos E Milla; James F Chmiel; Frank J Accurso; Donald R VanDevanter; Michael W Konstan; Geoffrey Yarranton; David E Geller
Journal:  Pediatr Pulmonol       Date:  2013-09-09

Review 2.  Associations and Disease-Disease Interactions of COVID-19 with Congenital and Genetic Disorders: A Comprehensive Review.

Authors:  Altijana Hromić-Jahjefendić; Debmalya Barh; Cecília Horta Ramalho Pinto; Lucas Gabriel Rodrigues Gomes; Jéssica Lígia Picanço Machado; Oladapo Olawale Afolabi; Sandeep Tiwari; Alaa A A Aljabali; Murtaza M Tambuwala; Ángel Serrano-Aroca; Elrashdy M Redwan; Vladimir N Uversky; Kenneth Lundstrom
Journal:  Viruses       Date:  2022-04-27       Impact factor: 5.818

Review 3.  Pseudomonas aeruginosa polymicrobial interactions during lung infection.

Authors:  Karishma Bisht; Jiwasmika Baishya; Catherine A Wakeman
Journal:  Curr Opin Microbiol       Date:  2020-02-12       Impact factor: 7.934

Review 4.  Cystic fibrosis.

Authors:  Felix Ratjen; Scott C Bell; Steven M Rowe; Christopher H Goss; Alexandra L Quittner; Andrew Bush
Journal:  Nat Rev Dis Primers       Date:  2015-05-14       Impact factor: 52.329

5.  SPLUNC1: a novel marker of cystic fibrosis exacerbations.

Authors:  Sara Khanal; Megan Webster; Naiqian Niu; Jana Zielonka; Myra Nunez; Geoffrey Chupp; Martin D Slade; Lauren Cohn; Maor Sauler; Jose L Gomez; Robert Tarran; Lokesh Sharma; Charles S Dela Cruz; Marie Egan; Theresa Laguna; Clemente J Britto
Journal:  Eur Respir J       Date:  2021-11-11       Impact factor: 33.795

6.  Expression of ACE2-a Key SARS-CoV-2 Entry Factor-Is Not Increased in the Nasal Mucosa of People with Cystic Fibrosis.

Authors:  Marc A Sala; Nikolay S Markov; Yuliya Politanska; Hiam Abdala-Valencia; Alexander V Misharin; Manu Jain
Journal:  Am J Respir Cell Mol Biol       Date:  2022-07       Impact factor: 7.748

7.  Viruses in bronchiectasis: a pilot study to explore the presence of community acquired respiratory viruses in stable patients and during acute exacerbations.

Authors:  Alicia B Mitchell; Bassel Mourad; Lachlan Buddle; Matthew J Peters; Brian G G Oliver; Lucy C Morgan
Journal:  BMC Pulm Med       Date:  2018-05-22       Impact factor: 3.317

Review 8.  Respiratory Viral Infections in Chronic Lung Diseases.

Authors:  Clemente J Britto; Virginia Brady; Seiwon Lee; Charles S Dela Cruz
Journal:  Clin Chest Med       Date:  2016-12-24       Impact factor: 2.878

Review 9.  Bacterial Community Interactions During Chronic Respiratory Disease.

Authors:  Allison L Welp; Jennifer M Bomberger
Journal:  Front Cell Infect Microbiol       Date:  2020-05-14       Impact factor: 5.293

10.  Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial.

Authors:  Anne B Chang; Keith Grimwood; Andrew C Wilson; Peter P van Asperen; Catherine A Byrnes; Kerry-Ann F O'Grady; Theo P Sloots; Colin F Robertson; Paul J Torzillo; Gabrielle B McCallum; Ian B Masters; Helen M Buntain; Ian M Mackay; Jacobus Ungerer; Joanne Tuppin; Peter S Morris
Journal:  Trials       Date:  2013-02-20       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.